Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Featured
Mintz Direct
May 1, 2021
On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.
Read More
Mintz Viewpoints
Search
Showing 1 - 8 of 8792 results
Exclusive Rights: Intellectual Property — US Signals Approval of IP Waiver for COVID-19 Vaccines
May 13, 2021 |Podcast |Viewpoint
Biden Administration Signals Support for International Entrepreneur Parole Rule
May 13, 2021 |Blog |Viewpoint
Fourth Time’s the Charm? How COVID-19 May Spur Congress to Pass Legislation Expanding Coverage for Pharmacist Services
May 12, 2021 |Blog |Viewpoint
Travel Alert – Update on U.S. Travel Bans
May 12, 2021 |Alert |Viewpoint
Revisions to National Interest Exceptions to Schengen Travel Ban
May 12, 2021 |Alert |Viewpoint
Biden Administration Bans Most Travel from India
May 12, 2021 |Alert |Viewpoint
News & Press Releases
Mintz Members Peter Cuomo and Muriel Liberto co-authored an article published in the March/April 2021 issue of IP Litigator that examined how the U.S. written description requirement is developing in the ‘unpredictable’ pharmaceutical and biotechnology-related arts. In their article, Mr. Cuomo and Dr. Liberto reviewed a line of post-Ariad “blaze marks” cases illustrating what may become a trend toward a higher bar for satisfying the written description requirement in the United States, particularly as applied to genus claims covering molecules large and small, such as antibodies, enzymes, and small organic molecules. Where the claim further relies upon functional language to define a genus of compounds, the authors cautioned that the bar is likely to be even higher to the extent this line of cases is followed.
In an article published by Communications Daily, Managing Member of Mintz’s Washington, D.C. Office and Chair of the firm’s Health Law, Communications, Antitrust & ML Strategies Division Susan Berson was quoted on the return to in-person work for attorneys and professional staff in the firm’s Washington, D.C. office, which she said was subject to regional and Centers for Disease Control and Prevention guidance. She added that the firm has demonstrated that clients can be served well remotely and likely will use a hybrid model long term.